These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 8233614)

  • 1. Chronobiology and chronotherapy of malaria: investigations with murine malaria models.
    Landau I; Caillard V; Beaute-Lafitte A; Chabaud A
    Parassitologia; 1993 Jul; 35 Suppl():55-7. PubMed ID: 8233614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in malaria research: parasite biology, chemotherapy and host/parasite relationships.
    Trigg PI
    Ann Ist Super Sanita; 1985; 21(3):271-90. PubMed ID: 3914847
    [No Abstract]   [Full Text] [Related]  

  • 3. The origins of antimalarial drug resistance.
    Hastings IM
    Trends Parasitol; 2004 Nov; 20(11):512-8. PubMed ID: 15471702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired fitness of drug-resistant malaria parasites: evidence and implication on drug-deployment policies.
    Babiker HA; Hastings IM; Swedberg G
    Expert Rev Anti Infect Ther; 2009 Jun; 7(5):581-93. PubMed ID: 19485798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Host-cell invasion by malaria parasites: insights from Plasmodium and Toxoplasma.
    Baum J; Gilberger TW; Frischknecht F; Meissner M
    Trends Parasitol; 2008 Dec; 24(12):557-63. PubMed ID: 18835222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The chemosensitivity of the rodent malarias--relationships with the biology of merozoites.
    Beauté-Lafitte A; Altemayer-Caillard V; Gonnet-Gonzalez F; Ramiaramanana L; Chabaud AG; Landau I
    Int J Parasitol; 1994 Nov; 24(7):981-6. PubMed ID: 7883449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Timing niches of 3 species of Plasmodium coexisting in a rodent in Central Africa].
    Cambie G; Landau I; Chabaud AG
    C R Acad Sci III; 1990; 310(5):183-8. PubMed ID: 2107960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Malaria and drug resistance].
    Kager PA; Wetsteyn JC
    Ned Tijdschr Geneeskd; 1996 Jan; 140(3):151-5. PubMed ID: 8618636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmodium vinckei: selection of a strain exhibiting stable resistance to arteether.
    Puri SK; Chandra R
    Exp Parasitol; 2006 Oct; 114(2):129-32. PubMed ID: 16624307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current status of malaria chemotherapy and the role of pharmacology in antimalarial drug research and development.
    Na-Bangchang K; Karbwang J
    Fundam Clin Pharmacol; 2009 Aug; 23(4):387-409. PubMed ID: 19709319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmodium vinckei petteri: identification of the stages sensitive to arteether.
    Caillard V; Beauté-Lafitte A; Chabaud AG; Landau I
    Exp Parasitol; 1992 Dec; 75(4):449-56. PubMed ID: 1493877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Competitive release of drug resistance following drug treatment of mixed Plasmodium chabaudi infections.
    de Roode JC; Culleton R; Bell AS; Read AF
    Malar J; 2004 Sep; 3():33. PubMed ID: 15367331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of poly(amidoamine) drug conjugates for the delivery of antimalarials to Plasmodium.
    Urbán P; Valle-Delgado JJ; Mauro N; Marques J; Manfredi A; Rottmann M; Ranucci E; Ferruti P; Fernàndez-Busquets X
    J Control Release; 2014 Mar; 177():84-95. PubMed ID: 24412735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Drug resistance of Plasmodium and rational application of antimalarials].
    Liu DQ
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2005 Oct; 23(5 Suppl):355-61. PubMed ID: 16562468
    [No Abstract]   [Full Text] [Related]  

  • 15. Heme metabolism of Plasmodium is a major antimalarial target.
    Padmanaban G; Rangarajan PN
    Biochem Biophys Res Commun; 2000 Feb; 268(3):665-8. PubMed ID: 10679261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel molecular targets for antimalarial chemotherapy.
    Jana S; Paliwal J
    Int J Antimicrob Agents; 2007 Jul; 30(1):4-10. PubMed ID: 17339102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can nature's defence against malaria be mimicked by the development of host-directed therapies?
    Foote SJ
    Pharmacogenomics J; 2004; 4(3):141-2. PubMed ID: 15037860
    [No Abstract]   [Full Text] [Related]  

  • 18. Rational approach to the treatment of malaria.
    Valecha N; Srivastava A; Sharma VP
    Natl Med J India; 1994; 7(6):281-7. PubMed ID: 7841881
    [No Abstract]   [Full Text] [Related]  

  • 19. Resistance to antimalarial compounds: methods and applications.
    Witkowski B; Berry A; Benoit-Vical F
    Drug Resist Updat; 2009; 12(1-2):42-50. PubMed ID: 19285915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different responses of three rodent Plasmodia species, Plasmodium yoelii 17XL, P. berghei NK65 and P. chabaudi AS on treatment with febrifugine and isofebrifugine mixture from Hydrangea macrophylla var. Otaksa leaf in ICR mice.
    Ishih A; Miyase T; Ohori K; Terada M
    Phytother Res; 2003 Jun; 17(6):650-6. PubMed ID: 12820234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.